Status:

COMPLETED

Improvisational Movement for People With Memory Loss and Their Caregivers

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Alzheimer's Disease (Incl Subtypes)

Dementia

Eligibility:

All Genders

60-85 years

Phase:

NA

Brief Summary

Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Changes in mood, gait, and balance are prominent secondary symptoms of Alzheimer's...

Detailed Description

Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Alzheimer's disease is the most common form of dementia, the most common neurodege...

Eligibility Criteria

Inclusion

  • Age 60-85 years
  • Adjudicated as having mild cognitive impairment or early-stage dementia of Alzheimer's, vascular, or mixed Alzheimer's/vascular type
  • MRI compatible
  • English speaking
  • Have study partner who is around the person with dementia approximately 10 hours/week and is willing to be an active study partner.
  • Able to attend bi-weekly intervention classes or come to study visits for no-contact control.
  • Not enrolled in another interventional study for at least 3 months prior to beginning this study.

Exclusion

  • Untreated depression
  • Other causes of dementia (for example, frontotemporal, early onset, Lewy body or Parkinsonian dementia)
  • Current cancer treatment or other major medical problems that might independently affect cognition or movement
  • Other neurological disorders (e.g., Parkinson disease, multiple sclerosis)
  • Taking medication that could negatively influence safety during intervention
  • Planned extensive travel during the study period
  • Any reason for which the study doctor or personal physician feels the intervention is contraindicated for the participant

Key Trial Info

Start Date :

February 6 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 26 2021

Estimated Enrollment :

104 Patients enrolled

Trial Details

Trial ID

NCT03333837

Start Date

February 6 2018

End Date

May 26 2021

Last Update

July 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States, 27104